Back to User profile » Dr Yu Ren

Papers published by Dr Yu Ren:

Corrigendum

LncRNA PVT1 promotes proliferation, invasion and epithelial–mesenchymal transition of renal cell carcinoma cells through downregulation of miR-16-5p [Corrigendum]

Ren Y, Huang W, Weng G, Cui P, Liang H, Li Y

OncoTargets and Therapy 2019, 12:7737-7738

Published Date: 20 September 2019

Corrigendum

LncRNA PVT1 promotes proliferation, invasion and epithelial–mesenchymal transition of renal cell carcinoma cells through downregulation of miR-16-5p [Corrigendum]

Ren Y, Huang W, Weng G, Cui P, Liang H, Li Y

OncoTargets and Therapy 2019, 12:5649-5650

Published Date: 12 July 2019

Retraction

Polydatin exerts anti-tumor effects against renal cell carcinoma cells via induction of caspase-dependent apoptosis and inhibition of the PI3K/Akt pathway [Retraction]

Jin Y-L, Xin L-M, Zhou C-C, Ren Y

OncoTargets and Therapy 2019, 12:4321-4322

Published Date: 4 June 2019

Original Research

LncRNA PVT1 promotes proliferation, invasion and epithelial–mesenchymal transition of renal cell carcinoma cells through downregulation of miR-16-5p

Ren Y, Huang W, Weng G, Cui P, Liang H, Li Y

OncoTargets and Therapy 2019, 12:2563-2575

Published Date: 5 April 2019

Original Research

Polydatin exerts anti-tumor effects against renal cell carcinoma cells via induction of caspase-dependent apoptosis and inhibition of the PI3K/Akt pathway

Jin YL, Xin LM, Zhou CC, Ren Y

OncoTargets and Therapy 2018, 11:8185-8195

Published Date: 16 November 2018